Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection

Title
Inhaled Edoxaban dry powder inhaler formulations: Development, characterization and their effects on the coagulopathy associated with COVID-19 infection
Authors
Keywords
Edoxaban, Dry powder inhaler formulation, Pulmonary drug delivery venous thromboembolism, FPF, COVID-19, Coagulation
Journal
INTERNATIONAL JOURNAL OF PHARMACEUTICS
Volume -, Issue -, Pages 121122
Publisher
Elsevier BV
Online
2021-09-21
DOI
10.1016/j.ijpharm.2021.121122

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started